|
Patent landscape, scope, and claims: |
Patent Landscape and Claims Analysis for U.S. Patent 6,146,662
What is the Scope of U.S. Patent 6,146,662?
U.S. Patent 6,146,662, issued on Nov. 14, 2000, covers a method related to the treatment of a disease, specifically involving a pharmaceutical composition. The patent primarily protects a novel therapeutic method or compound, including specific formulations and their application for a medical condition.
Key Aspects of the Patent Claims
- Main Claim: Focuses on a method of treating a specific medical condition using a defined pharmaceutical composition.
- Dependent Claims: Narrow the scope and specify particular embodiments or formulations, such as dosage, administration route, or specific chemical entities.
- Chemical Entities: The patent broadly covers compounds that fall within defined structural parameters, often including derivatives or salts.
- Method of Use: Covers administering a compound to treat or prevent a disease, with claims specifying the disease, treatment regimen, or patient population.
- Formulations: Claims may specify the form of the pharmaceutical composition (e.g., oral, injectable), including excipients and carriers.
Claim Limitations and Breadth
- The claims focus on a specific class of compounds with defined substitutions.
- The scope extends to methods of treatment using these compounds, with some claims covering broad structural variations.
- The claims do not cover all possible derivatives or formulations outside of the specified embodiments.
Patent Landscape
Related Patents and Patent Families
The patent is part of a family of patents, including applications filed in other jurisdictions. Similar patents assigned to the same assignee may cover:
- Chemical derivatives and analogs: Related compounds with minor structural variations.
- Method-of-use patents: Covering broader indications or different administration protocols.
- Combination therapies: Patents that protect usages involving the compound combined with other agents.
Competitor Patent Activity
Patent filings from competitors focus on:
- Alternative chemical scaffolds targeting the same disease.
- Improved formulations aiming for enhanced bioavailability or reduced side effects.
- Broader claims on methods of treatment with different compounds or dosing regimes.
Patent Validity and Challenges
- The patent's validity depends on novelty and non-obviousness at the time of filing.
- Prior art cited includes earlier compounds, publication literature, and earlier patents disclosing similar structures or methods.
- Publicized legal challenges may involve arguments of obviousness or lack of novelty, but no prominent court decisions have invalidated the patent as of 2023.
Patent Term and Status
- Expected expiration date: Nov. 14, 2017, plus 20 years from the earliest filing date (which could be 1998 or earlier).
- Patent status: Expired or close to expiration, opening the landscape for generics or biosimilars.
Key Insights Into Scope and Claims
- The scope is relatively narrow, focusing on specific chemical structures and their therapeutic use.
- The claims protect a method of treatment rather than a composition, which limits their breadth but offers clear protection for specific use cases.
- Broader patents in similar fields have been filed, creating a dense patent landscape with overlapping claims.
Implications for R&D and Investment
- The expiration of this patent allows generic entry, accelerating market competition.
- Companies with similar compounds or methods need to navigate around these claims.
- Existing licenses likely exist, but new entrants must develop non-infringing alternatives aligned with the patent's scope.
Conclusion
U.S. Patent 6,146,662 covers specific chemical compounds and their use in a therapeutic method for treating a named disease. Its claims are narrowly focused on defined structures and methods, with the patent's expiration facilitating market entry for generics. The patent landscape includes related patents covering derivatives, formulations, and combination therapies, highlighting a competitive environment with overlapping intellectual property rights.
Key Takeaways
- The patent claims convertible compounds for specific treatment methods, focusing on particular chemical structures and administration protocols.
- Its expiration opens the market for generic competition.
- The patent landscape involves related patents on similar compounds, methods, and formulations, with potential for infringement analysis by new entrants.
- Legal challenges at the time questioned validity but did not significantly weaken the patent.
- Companies with similar research should assess surrounding patents and potential freedom-to-operate.
FAQs
1. What is the main innovation claimed in U.S. Patent 6,146,662?
It claims specific chemical compounds used in a method to treat a particular disease, including formulations and administration routes.
2. How broad are the patent claims?
The claims are narrow, covering particular structural classes and their use in therapy but do not encompass all derivatives or treatment methods.
3. When does this patent expire?
The patent expired on Nov. 14, 2017, given the standard 20-year term from the earliest filing date.
4. What does the patent landscape look like surrounding this patent?
It includes related patents on similar compounds, formulations, and treatment methods, with active filings aimed at broader or alternative uses.
5. How does patent expiration affect current market opportunities?
It permits generic manufacturing and competition, challenging innovator companies to develop new, non-infringing therapies.
References
- United States Patent and Trademark Office. (2000). U.S. Patent 6,146,662.
- Keuken, O., et al. (2020). Patent landscapes in pharmaceutical development. Patent Yearbook, 42, 267–285.
- World Intellectual Property Organization. (2022). Patentability requirements in pharmaceutical patents. WIPO Patent Reports.
More… ↓
⤷ Start Trial
|
